BURT A ADELMAN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BURT A ADELMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BURT A ADELMAN. BURT A ADELMAN is an Executive VP Development in BIOGEN INC. ($IDPH) and an Executive VP, Development in BIOGEN INC. ($IDPH) and a CMO & EVP, R&D in DYAX CORP ($DYAX) and a Director in CATABASIS PHARMACEUTICALS INC ($CATB).
Address: BIOGEN INC LEGAL DEPARTMENT 14 CAMBRIDGE CENTER CAMBRIDGE 02142 MA
Companies in which BURT A ADELMAN is an Insider
BIOGEN INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BURT A ADELMAN: Executive VP Development, Executive VP, Development
Holdings: 12,269 shares
Latest Transaction: Mar 31 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CATABASIS PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BURT A ADELMAN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 12 2020
$CATB Market Capitalization: $22.76M
$CATB Previous Close: $1.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
DYAX CORP
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of BURT A ADELMAN: CMO & EVP, R&D
Holdings: 0 shares
Latest Transaction: Jan 22 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of BURT A ADELMAN
Sentiment: All, IDPH, CATB, DYAX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 12 2020 | CATB | CATABASIS PHARMACE ... | ADELMAN BURT A | Director | Option Exercise | A | 6.17 | 7,500 | 46,275 | 7,500 | |
| Jun 05 2019 | CATB | CATABASIS PHARMACE ... | ADELMAN BURT A | Director | Option Exercise | A | 6.53 | 7,500 | 48,975 | 7,500 | |
| Jun 07 2018 | CATB | CATABASIS PHARMACE ... | ADELMAN BURT A | Director | Option Exercise | A | 1.48 | 14,000 | 20,720 | 14,000 | |
| Jul 28 2017 | CATB | CATABASIS PHARMACE ... | ADELMAN BURT A | Director | Option Exercise | A | 1.27 | 6,500 | 8,255 | 6,500 | |
| Apr 07 2016 | CATB | CATABASIS PHARMACE ... | ADELMAN BURT A | Director | Option Exercise | A | 4.80 | 13,000 | 62,400 | 13,000 | |
| Jan 22 2016 | DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Option Exercise | D | 15.23 | 500,000 | 7,615,000 | 0 | |
| Jan 22 2016 | DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Option Exercise | D | 10.20 | 225,000 | 2,295,000 | 0 |